CDKN2A and Barrett esophagus: The aberrant expressions of p53 and p16 reaction in BE-IND progressor cohorts were significantly associated with progression from BE-IND to LGD, suggesting the aberrant p53 and p16 expressions in BE-IND to be risk predictors of progression from BE-IND to LGD.